Reuters logo
BRIEF-NewLink Genetics forecasts co will have about $100 million in cash and cash equivalents on balance sheet
September 25, 2017 / 10:45 AM / in 3 months

BRIEF-NewLink Genetics forecasts co will have about $100 million in cash and cash equivalents on balance sheet

Sept 25 (Reuters) - NewLink Genetics Corp

* NewLink Genetics - forecasts that co will have about $100 million in cash and cash equivalents on its balance sheet as of December 31, 2017 - SEC filing Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below